Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Mitochondrial abnormalities are increasingly recognized as a hallmark of Alzheimer's disease (AD).
• Previous research has primarily focused on established AD, with limited investigation into at-risk or early-stage populations.
• Understanding mitochondrial function in early cognitive decline is crucial for timely therapeutic interventions.

Purpose of the Study:

• To investigate mitochondrial electron transport chain (ETC) complex activity in peripheral tissues of individuals with AD, mild cognitive impairment (MCI), and healthy controls.
• To determine if mitochondrial deficiencies are present at the earliest symptomatic stages of cognitive decline.

Main Methods:

• Platelet and lymphocyte mitochondria were isolated from participants across three groups: AD, MCI, and non-demented aged controls.
• Activity levels of Complexes I, III, and IV of the mitochondrial ETC were assessed.
• Western blotting was employed to ensure accurate quantification and control for sample enrichment.

Main Results:

• Significant reductions in Complex IV activity were observed in individuals with MCI compared to controls.
• Individuals with AD exhibited significant declines in both Complex III and Complex IV activity.
• Complex I activity did not show significant differences across the groups.

Conclusions:

• Mitochondrial electron transport chain deficiencies, particularly in Complex IV, are present in mild cognitive impairment, suggesting they are an early feature of AD pathogenesis.
• These findings confirm and extend the role of mitochondrial dysfunction to the earliest symptomatic stages of Alzheimer's disease.
• Peripheral mitochondrial analysis may serve as a potential biomarker for early AD detection.